{{Rsnum
|rsid=321029
|Gene=CYSLTR1
|Chromosome=X
|position=78328249
|Orientation=plus
|GMAF=0.2739
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=CYSLTR1
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 16.9 | 13.8 | 69.2
| HCB | 20.5 | 20.5 | 59.1
| JPT | 34.1 | 38.6 | 27.3
| YRI | 3.4 | 4.1 | 92.4
| ASW | 0.0 | 0.0 | 0.0
| CHB | 20.5 | 20.5 | 59.1
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=20003473
|Title=Variable expression of cysteinyl leukotriene type I receptor splice variants in asthmatic females with different promoter haplotypes
|OA=1
}}

{{PMID Auto
|PMID=17406065
|Title=Functional polymorphism and differential regulation of CYSLTR1 transcription in human airway smooth muscle and monocytes.
}}

{{PMID Auto
|PMID=18179784
|Title=MEGF10 association with schizophrenia.
|OA=1
}}

{{PMID Auto
|PMID=18404645
|Title=FBXL21 association with schizophrenia in Irish family and case-control samples.
|OA=1
}}

{{PMID Auto
|PMID=20592916
|Title=Pharmacogenomic approaches to asthma treatment.
|OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}